BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres J, Halfvarson J, Rodríguez-lago I, Hedin CRH, Jess T, Dubinsky M, Croitoru K, Colombel J. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021;15:1443-54. [DOI: 10.1093/ecco-jcc/jjab048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Che H, Jatsenko T, Lannoo L, Stanley K, Dehaspe L, Vancoillie L, Brison N, Parijs I, Van Den Bogaert K, Devriendt K, Severi S, De Langhe E, Vermeire S, Verstockt B, Van Calsteren K, Vermeesch JR. Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets. npj Genom Med 2022;7. [DOI: 10.1038/s41525-022-00325-w] [Reference Citation Analysis]
2 Liu C, Yu R, Zhang J, Wei S, Xue F, Guo Y, He P, Shang L, Dong W. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Front Immunol 2022;13:972079. [DOI: 10.3389/fimmu.2022.972079] [Reference Citation Analysis]
3 Deng L, Wang S, Zhang R, Huang J, Lin Y, Liu X, Lu Z, Li M, Tan W. Protective effects of (R)-enantiomers but not (S)-enantiomers of β2-adrenergic receptor agonists against acute colitis: The role of β2AR. Int Immunopharmacol 2022;110:108997. [PMID: 35767902 DOI: 10.1016/j.intimp.2022.108997] [Reference Citation Analysis]
4 Agrawal M, Allin KH, Petralia F, Colombel JF, Jess T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat Rev Gastroenterol Hepatol 2022;19:399-409. [PMID: 35301463 DOI: 10.1038/s41575-022-00593-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Luo X, Zhang J, Li Z, Yang R. Diagnosis of ulcerative colitis from endoscopic images based on deep learning. Biomedical Signal Processing and Control 2022;73:103443. [DOI: 10.1016/j.bspc.2021.103443] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Torres J, Ungaro RC, Colombel JF. Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We? Gastroenterology 2022;162:1452-5. [PMID: 34995527 DOI: 10.1053/j.gastro.2021.07.051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mahadea D, Adamczewska E, Ratajczak AE, Rychter AM, Zawada A, Eder P, Dobrowolska A, Krela-Kaźmierczak I. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review. Nutrients 2021;13:4008. [PMID: 34836263 DOI: 10.3390/nu13114008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Lundgren D, Widbom L, Hultdin J, Karling P. Preclinical Markers in Inflammatory Bowel Disease. A Nested Case–Control Study. Crohn's & Colitis 360 2021;3:otab072. [DOI: 10.1093/crocol/otab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Noor NM, Sousa P, Paul S, Roblin X. Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD. Inflamm Bowel Dis 2021:izab228. [PMID: 34480558 DOI: 10.1093/ibd/izab228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rodríguez-Lago I, Agirre U, Intxaurza N, Cantero D, Cabriada JL, Barreiro-de Acosta M. Increased use of healthcare resources during the preclinical period of inflammatory bowel disease. Dig Liver Dis 2021;53:927-30. [PMID: 33994123 DOI: 10.1016/j.dld.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Verstockt B, Noor NM, Marigorta UM, Pavlidis P, Deepak P, Ungaro RC; Scientific Workshop Steering Committee . Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy. J Crohns Colitis 2021;15:1431-42. [PMID: 33730756 DOI: 10.1093/ecco-jcc/jjab050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]